Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7497)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2016 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lian PL, Liu Z, Yang GY, Zhao R, Zhang ZY, Chen YG, Zhuang ZN, Xu KS. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. World J Gastroenterol 2016; 22(14): 3852-3859 [PMID: 27076771 DOI: 10.3748/wjg.v22.i14.3852] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i14/3852.htm |
| Number | Citing Articles |
| 1 |
Yue Zhou, Lei Tao, Jiahao Qiu, Jing Xu, Xinyu Yang, Yu Zhang, Xinyu Tian, Xinqi Guan, Xiaobo Cen, Yinglan Zhao. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01823-2
|
| 2 |
Zhe Zhang, Zheng Wang, Tong Liu, Jiayou Tang, Yanqing Liu, Tiantian Gou, Kangli Chen, Li Wang, Juan Zhang, Yang Yang, Huan Zhang. Exploring the role of ITGB6: fibrosis, cancer, and other diseases. Apoptosis 2024; 29(5-6): 570 doi: 10.1007/s10495-023-01921-6
|
| 3 |
Sabine Raab-Westphal, John Marshall, Simon Goodman. Integrins as Therapeutic Targets: Successes and Cancers. Cancers 2017; 9(9): 110 doi: 10.3390/cancers9090110
|
| 4 |
Zhi‐Guo Shan, Zhen‐Wei Sun, Li‐Qun Zhao, Qiang Gou, Zhi‐Fu Chen, Jin‐Yu Zhang, Weisan Chen, Chong‐Yu Su, Nan You, Yuan Zhuang, Yong‐Liang Zhao. Upregulation of Tubulointerstitial nephritis antigen like 1 promotes gastric cancer growth and metastasis by regulating multiple matrix metallopeptidase expression. Journal of Gastroenterology and Hepatology 2021; 36(1): 196 doi: 10.1111/jgh.15150
|
| 5 |
Jun Niu, Zequn Li. The roles of integrin αvβ6 in cancer. Cancer Letters 2017; 403: 128 doi: 10.1016/j.canlet.2017.06.012
|
| 6 |
Mauricio Urquiza, Valentina Guevara, Erika Diaz-Sana, Felipe Mora. The Role of αvβ6 Integrin Binding Molecules in the Diagnosis and Treatment of Cancer. Current Organic Chemistry 2020; 24(21): 2393 doi: 10.2174/1385272824999200528124936
|
| 7 |
Ana Margarida Moreira, Joana Pereira, Soraia Melo, Maria Sofia Fernandes, Patrícia Carneiro, Raquel Seruca, Joana Figueiredo. The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression. Cells 2020; 9(2): 394 doi: 10.3390/cells9020394
|
| 8 |
Alexandra Desnoyers, Carlos González, Pedro Pérez-Segura, Atanasio Pandiella, Eitan Amir, Alberto Ocaña. Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis. Molecular Diagnosis & Therapy 2020; 24(2): 143 doi: 10.1007/s40291-020-00450-1
|
| 9 |
Junjian Yu, Wenyu Jia, Qi Liu, Antai Yuan, Zhuoyu Jia, YuQi Sun, Zequn Li, Shougen Cao. The association and clinicopathological significance of Integrin alphavbeta6 and Rac1 expression in gastric carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1347270
|
| 10 |
Justus Körfer, Florian Lordick, Ulrich T. Hacker. Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View. Cancers 2021; 13(20): 5216 doi: 10.3390/cancers13205216
|
| 11 |
Hui Wang, Meng Zhang, Ying Zhang, Yinan Liu, Mengying Wang, Yue Liu, Yucheng Liao, Zhengzheng Li, Yiping Feng, Jinghong Chen. The decreased expression of integrin αv is involved in T-2 toxin-induced extracellular matrix degradation in chondrocytes. Toxicon 2021; 199: 109 doi: 10.1016/j.toxicon.2021.06.006
|
| 12 |
Lynsey Whilding, Leena Halim, Benjamin Draper, Ana Parente-Pereira, Tomasz Zabinski, David Davies, John Maher. CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies. Cancers 2019; 11(5): 674 doi: 10.3390/cancers11050674
|
| 13 |
Biqing Chen, Jiaqi Liu. Prospects and challenges of CAR-T in the treatment of ovarian cancer. International Immunopharmacology 2024; 133: 112112 doi: 10.1016/j.intimp.2024.112112
|
| 14 |
Zequn Li, Yuqi Sun, Jianfei Xu, Hao Yang, Xiaodong Liu, Yulong Tian, Shougen Cao, Yanbing Zhou. Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.770997
|
| 15 |
Bibo Tan, Yong Li, Xiaoming Shi, Liqiao Fan, Qun Zhao, Yanli Liu, Ming Tan, Qingwei Liu, Nan Jia. Expression of Vav3 protein and its prognostic value in patients with gastric cancer. Pathology - Research and Practice 2017; 213(5): 435 doi: 10.1016/j.prp.2017.01.028
|
| 16 |
Min Jiang, Changyin Fang, Yongping Ma. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Gastric Cancer. Biomolecules 2023; 13(3): 469 doi: 10.3390/biom13030469
|
| 17 |
Mehdi Rajabi, Mary Adeyeye, Shaker A. Mousa. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer. Current Medicinal Chemistry 2019; 26(30): 5664 doi: 10.2174/0929867326666190620100800
|
| 18 |
Biao Zhang, Bingqian Huang, Xiaonan Zhang, Shuang Li, Jingyi Zhu, Xu Chen, Huiyi Song, Dong Shang. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1217654
|
| 19 |
Mauricio Urquiza, Daniela Benavides-Rubio, Silvia Jimenez-Camacho. Structural analysis of peptide binding to integrins for cancer detection and treatment. Biophysical Reviews 2023; 15(4): 699 doi: 10.1007/s12551-023-01084-3
|
| 20 |
Yoko Matsumoto, Hidenori Kage, Mizuki Morota, Koichi Zokumasu, Takahiro Ando, Keita Maemura, Kousuke Watanabe, Masanori Kawakami, Munetoshi Hinata, Tetsuo Ushiku, Jun Nakajima, Takahide Nagase. Integrin alpha 2 is associated with tumor progression and postoperative recurrence in non-small cell lung cancer. Japanese Journal of Clinical Oncology 2023; 53(1): 63 doi: 10.1093/jjco/hyac148
|
| 21 |
Adith S. Arun, Clifford G. Tepper, Kit S. Lam. Identification of integrin drug targets for 17 solid tumor types. Oncotarget 2018; 9(53): 30146 doi: 10.18632/oncotarget.25731
|
| 22 |
Xingxing Zhang, Xu Chen, Jiayun Liu, Yaqi Li, Jian Wu, Menglin Chen, Ruijuan Zhang, Xintian Xu, Tianyi Xu, Qingmin Sun. A novel metabolism-related prognostic gene development and validation in gastric cancer. Clinical and Translational Oncology 2022; 25(2): 447 doi: 10.1007/s12094-022-02958-w
|
| 23 |
Tapasi Roy, Vineet Kumar Mishra, Sudipta Mallick, Snehasikta Swarnakar. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2021; : 1 doi: 10.1007/978-981-15-4501-6_14-1
|
| 24 |
Takuro Hirano, Yoshinari Shinsato, Kan Tanabe, Nayuta Higa, Muhammad Kamil, Kohichi Kawahara, Masatatsu Yamamoto, Kentaro Minami, Michiko Shimokawa, Takaaki Arigami, Shigehiro Yanagita, Daisuke Matushita, Yoshikazu Uenosono, Sumiya Ishigami, Yuko Kijima, Kosei Maemura, Ikumi Kitazono, Akihide Tanimoto, Tatsuhiko Furukawa, Shoji Natsugoe. FARP1 boosts CDC42 activity from integrin αvβ5 signaling and correlates with poor prognosis of advanced gastric cancer. Oncogenesis 2020; 9(2) doi: 10.1038/s41389-020-0190-7
|
| 25 |
Qi Sun, Xiwen Dong, Yukui Shang, Fengkai Sun, Jun Niu, Fanni Li. Integrin αvβ6 predicts poor prognosis and promotes resistance to cisplatin in hilar cholangiocarcinoma. Pathology - Research and Practice 2020; 216(7): 153022 doi: 10.1016/j.prp.2020.153022
|
| 26 |
Aline Kowalski-Chauvel, Guy Teissier, Christine Toulas, Elizabeth Cohen-jonathan-moyal, Catherine Seva. By modulating α2β1 integrin signalling, gastrin increases adhesion oF AGS-GR gastric cancer cells. Experimental Cell Research 2018; 362(2): 498 doi: 10.1016/j.yexcr.2017.12.014
|
| 27 |
Ewa Brzozowska, Sameer Deshmukh. Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment. International Journal of Molecular Sciences 2022; 23(20): 12346 doi: 10.3390/ijms232012346
|
| 28 |
Izabela Łasiñska, Jacek Mackiewicz. Integrins as A New Target for Cancer Treatment. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(5): 580 doi: 10.2174/1871520618666181119103413
|
| 29 |
Chao Chen, Xiaoxu Ge, Yamei Zhao, Da Wang, Limian Ling, Shu Zheng, Kefeng Ding, Jian Wang, Lifeng Sun. Molecular Alterations in Metastatic Ovarian Cancer From Gastrointestinal Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.605349
|
| 30 |
Dongliang Liu, Shaojun Liu, Yu Fang, Liu Liu, Kongwang Hu. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.816230
|
| 31 |
Tapasi Roy, Vineet Kumar Mishra, Sudipta Mallick, Snehasikta Swarnakar. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2022; : 153 doi: 10.1007/978-981-15-9411-3_14
|
| 32 |
Ruben D. Houvast, Maurice van Duijvenvoorde, Kira Thijse, Wobbe O. de Steur, Lioe-Fee de Geus-Oei, A. Stijn. L. P. Crobach, Jacobus Burggraaf, Alexander L. Vahrmeijer, Peter J. K. Kuppen. Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation. Molecular Diagnosis & Therapy 2024; doi: 10.1007/s40291-024-00755-5
|